Datasets:
Gene string | Gene synonym string | Ensembl string | Gene description string | Uniprot string | Chromosome string | Position string | Protein class string | Biological process string | Molecular function string | Disease involvement string | Evidence string | HPA evidence string | UniProt evidence string | NeXtProt evidence string | RNA tissue specificity string | RNA tissue distribution string | RNA tissue specificity score float64 | RNA tissue specific nTPM string | RNA single cell type specificity string | RNA single cell type distribution string | RNA single cell type specificity score float64 | RNA single cell type specific nTPM string | RNA single nuclei brain specificity string | RNA single nuclei brain distribution string | RNA single nuclei brain specificity score float64 | RNA single nuclei brain specific nTPM string | RNA cancer specificity string | RNA cancer distribution string | RNA cancer specificity score float64 | RNA cancer specific FPKM string | RNA brain regional specificity string | RNA brain regional distribution string | RNA brain regional specificity score float64 | RNA brain regional specific nTPM string | RNA blood cell specificity string | RNA blood cell distribution string | RNA blood cell specificity score float64 | RNA blood cell specific nTPM string | RNA blood lineage specificity string | RNA blood lineage distribution string | RNA blood lineage specificity score float64 | RNA blood lineage specific nTPM string | RNA cell line specificity string | RNA cell line distribution string | RNA cell line specificity score float64 | RNA cell line specific nTPM string | RNA tissue cell type enrichment string | RNA mouse brain regional specificity string | RNA mouse brain regional distribution string | RNA mouse brain regional specificity score float64 | RNA mouse brain regional specific nTPM string | RNA pig brain regional specificity string | RNA pig brain regional distribution string | RNA pig brain regional specificity score float64 | RNA pig brain regional specific nTPM string | Antibody string | Reliability (IH) string | Reliability (Mouse Brain) string | Reliability (IF) string | Subcellular location string | Secretome location string | Secretome function string | CCD Protein string | CCD Transcript string | Blood concentration - Conc. blood IM [pg/L] float64 | Blood concentration - Conc. blood MS [pg/L] float64 | Blood expression cluster string | Tissue expression cluster string | Brain expression cluster string | Cell line expression cluster string | Single cell expression cluster string | Interactions float64 | Subcellular main location string | Subcellular additional location string | Antibody RRID string | Cancer prognostics - Bladder Urothelial Carcinoma (TCGA) string | Cancer prognostics - Breast Invasive Carcinoma (TCGA) string | Cancer prognostics - Breast Invasive Carcinoma (validation) string | Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA) string | Cancer prognostics - Colon Adenocarcinoma (TCGA) string | Cancer prognostics - Colon Adenocarcinoma (validation) string | Cancer prognostics - Glioblastoma Multiforme (TCGA) string | Cancer prognostics - Glioblastoma Multiforme (validation) string | Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA) string | Cancer prognostics - Kidney Chromophobe (TCGA) string | Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA) string | Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation) string | Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA) string | Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA) string | Cancer prognostics - Liver Hepatocellular Carcinoma (validation) string | Cancer prognostics - Lung Adenocarcinoma (TCGA) string | Cancer prognostics - Lung Adenocarcinoma (validation) string | Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA) string | Cancer prognostics - Lung Squamous Cell Carcinoma (validation) string | Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA) string | Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation) string | Cancer prognostics - Pancreatic Adenocarcinoma (TCGA) string | Cancer prognostics - Pancreatic Adenocarcinoma (validation) string | Cancer prognostics - Prostate Adenocarcinoma (TCGA) string | Cancer prognostics - Rectum Adenocarcinoma (TCGA) string | Cancer prognostics - Rectum Adenocarcinoma (validation) string | Cancer prognostics - Skin Cuteneous Melanoma (TCGA) string | Cancer prognostics - Stomach Adenocarcinoma (TCGA) string | Cancer prognostics - Testicular Germ Cell Tumor (TCGA) string | Cancer prognostics - Thyroid Carcinoma (TCGA) string | Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA) string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TSPAN6 | T245, TM4SF6, TSPAN-6 | ENSG00000000003 | Tetraspanin 6 | O43657 | X | 100627108-100639991 | Predicted membrane proteins | null | null | null | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in many | null | null | Cell type enriched | Detected in many | 6 | Late spermatids: 1752.2 | Cell type enhanced | Detected in many | null | astrocyte: 32.6;ependymal cell: 58.3 | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Immune cell enhanced | Detected in some | null | naive CD4 T-cell: 2.1 | Lineage enriched | Detected in single | 7 | T-cells: 2.1 | Low cancer specificity | Detected in many | null | null | Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Testis - Late spermatids, Thyroid gland - Thyroid glandular cells | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA004109 | Approved | null | Approved | Nucleoli fibrillar center,Cell Junctions,Cytosol | null | null | null | null | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 8: Ciliated cells - Cilium organization | Cluster 3: Choroid plexus - Cilium | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 36: Late spermatids - Unknown function | 2 | Cell Junctions, Cytosol | Nucleoli fibrillar center | HPA004109: AB_1080301 | unprognostic (1.57e-1) | unprognostic (2.05e-1) | unprognostic (1.71e-1) | unprognostic (3.61e-1) | unprognostic (3.77e-2) | unprognostic (1.13e-2) | unprognostic (4.18e-2) | unprognostic (1.93e-1) | unprognostic (2.39e-4) | unprognostic (4.52e-1) | unprognostic (4.92e-6) | unprognostic (3.04e-2) | unprognostic (1.29e-2) | unprognostic (2.25e-1) | unprognostic (1.39e-2) | unprognostic (6.76e-2) | unprognostic (6.58e-3) | unprognostic (3.61e-2) | unprognostic (1.12e-1) | unprognostic (4.14e-2) | unprognostic (2.25e-1) | unprognostic (7.49e-5) | unprognostic (1.11e-1) | unprognostic (3.30e-2) | unprognostic (3.36e-3) | unprognostic (4.23e-3) | unprognostic (1.89e-2) | unprognostic (7.95e-2) | unprognostic (2.01e-1) | unprognostic (4.60e-2) | unprognostic (1.59e-1) |
TNMD | BRICD4, ChM1L, myodulin, TEM, tendin | ENSG00000000005 | Tenomodulin | Q9H2S6 | X | 100584936-100599885 | Predicted membrane proteins | null | null | null | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in some | null | adipose tissue: 20.4;breast: 12.5;seminal vesicle: 25.2 | Cell type enriched | Detected in some | 6 | Adipocytes: 72.2 | Cell type enhanced | Detected in single | null | choroid plexus epithelial cell: 2.3 | Low cancer specificity | Detected in some | null | null | Low region specificity | Detected in some | null | null | Not detected in immune cells | Not detected | null | null | Not detected | Not detected | null | null | Group enriched | Detected in some | 5 | testis cancer: 1.1;Uterine cancer: 1.3 | Skeletal muscle - Fibroblasts | Low region specificity | Detected in many | null | null | Low region specificity | Detected in many | null | null | HPA034961, HPA055634 | Uncertain | null | null | null | null | null | null | null | null | null | null | Cluster 7: Adipose tissue - Mixed function | Cluster 36: Choroid plexus - Mixed function | Cluster 34: Testis cancer - Unknown function | Cluster 41: Adipocytes & Endothelial cells - Mixed function | 1 | null | null | HPA034961: AB_10670285, HPA055634: AB_2682868 | null | null | unprognostic (2.09e-1) | null | unprognostic (1.68e-1) | null | unprognostic (6.13e-3) | null | null | null | unprognostic (1.21e-3) | null | null | null | null | null | null | null | null | null | null | null | null | null | unprognostic (2.21e-3) | null | null | null | unprognostic (1.55e-1) | null | null |
DPM1 | CDGIE, MPDS | ENSG00000000419 | Dolichyl-phosphate mannosyltransferase subunit 1, catalytic | O60762 | 20 | 50934867-50959140 | Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins | null | Glycosyltransferase, Transferase | Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in all | null | Basal respiratory cells: 234.7;Syncytiotrophoblasts: 265.5 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Adrenal gland - Adrenal cortex cells | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA051818 | Approved | null | null | null | null | null | null | null | null | null | Cluster 33: Non-specific - ATP binding | Cluster 35: Non-specific - Mitochondria | Cluster 21: Non-specific - Metabolism | Cluster 62: Non-specific - Plasma proteins | Cluster 35: Respiratory epithelial cells - Unknown function | 20 | null | null | HPA051818: AB_2681624 | unprognostic (3.18e-1) | unprognostic (1.74e-2) | unprognostic (5.36e-2) | unprognostic (1.68e-1) | unprognostic (8.80e-2) | unprognostic (1.49e-1) | unprognostic (8.45e-2) | unprognostic (7.06e-2) | unprognostic (1.03e-3) | unprognostic (1.66e-1) | unprognostic (6.27e-3) | unprognostic (8.16e-2) | unprognostic (1.76e-2) | unprognostic (6.46e-6) | unprognostic (9.90e-3) | unprognostic (7.73e-2) | unprognostic (1.72e-2) | unprognostic (1.22e-1) | unprognostic (1.91e-1) | unprognostic (8.15e-2) | unprognostic (1.26e-2) | unprognostic (1.64e-3) | unprognostic (1.57e-1) | unprognostic (5.86e-2) | unprognostic (3.10e-3) | unprognostic (7.21e-3) | unprognostic (6.73e-2) | unprognostic (4.37e-1) | unprognostic (1.73e-1) | unprognostic (2.03e-3) | unprognostic (7.59e-2) |
SCYL3 | PACE-1, PACE1 | ENSG00000000457 | SCY1 like pseudokinase 3 | Q8IZE3 | 1 | 169849631-169894267 | Enzymes, Predicted intracellular proteins | null | null | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Low cell type specificity | Detected in many | null | null | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Liver - Hepatocytes | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA005624, HPA072383 | Approved | null | Supported | Golgi apparatus,Cytosol | null | null | null | null | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 1: Liver & Kidney - Metabolism | Cluster 50: Non-specific - Nucleic acid binding | Cluster 45: Non-specific - Nuclear processes | Cluster 55: Non-specific - Transcription | 23 | Golgi apparatus, Cytosol | null | HPA005624: AB_1854916, HPA072383: | unprognostic (3.28e-1) | unprognostic (1.44e-1) | unprognostic (2.23e-1) | unprognostic (2.20e-2) | unprognostic (2.36e-1) | unprognostic (7.49e-2) | unprognostic (2.41e-2) | unprognostic (6.83e-2) | unprognostic (8.54e-3) | unprognostic (9.70e-3) | unprognostic (8.33e-3) | unprognostic (3.64e-2) | unprognostic (2.88e-1) | unprognostic (2.00e-1) | unprognostic (3.30e-2) | unprognostic (2.57e-1) | unprognostic (4.61e-2) | unprognostic (1.54e-1) | unprognostic (2.06e-1) | unprognostic (3.95e-1) | unprognostic (5.87e-2) | unprognostic (1.31e-1) | unprognostic (2.85e-2) | unprognostic (3.03e-1) | unprognostic (2.05e-1) | unprognostic (1.12e-1) | unprognostic (2.20e-1) | unprognostic (1.57e-1) | unprognostic (1.70e-1) | unprognostic (7.81e-2) | unprognostic (1.02e-1) |
C1orf112 | FLJ10706 | ENSG00000000460 | Chromosome 1 open reading frame 112 | Q9NSG2 | 1 | 169662007-169854080 | Predicted intracellular proteins | null | null | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in many | null | parathyroid gland: 13.0 | Cell type enhanced | Detected in many | null | Microglial cells: 28.6;Spermatocytes: 36.9 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in many | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in many | null | null | Low lineage specificity | Detected in many | null | null | Low cancer specificity | Detected in all | null | null | Skin - Mitotic cells (Skin), Testis - Spermatocytes | Low region specificity | Detected in many | null | null | Low region specificity | Detected in all | null | null | HPA023778, HPA024451 | Uncertain | null | Supported | Nucleoplasm,Nucleoli | null | null | null | null | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 16: Non-specific - Transcription | Cluster 55: Non-specific - Transcription | Cluster 45: Non-specific - Nuclear processes | Cluster 58: Macrophages - Innate immune response | 14 | Nucleoplasm | Nucleoli | HPA023778: AB_1848665, HPA024451: AB_1848667 | unprognostic (5.40e-3) | unprognostic (6.36e-2) | unprognostic (3.03e-2) | unprognostic (3.39e-2) | unprognostic (2.38e-3) | unprognostic (5.45e-2) | unprognostic (1.03e-1) | unprognostic (1.58e-2) | unprognostic (2.87e-2) | null | unprognostic (6.97e-4) | unprognostic (1.94e-2) | null | unprognostic (3.57e-3) | unprognostic (2.09e-2) | unprognostic (2.24e-4) | unprognostic (8.25e-5) | unprognostic (5.68e-2) | unprognostic (1.47e-1) | unprognostic (3.99e-1) | unprognostic (5.71e-1) | unprognostic (2.66e-5) | unprognostic (1.12e-2) | null | unprognostic (2.85e-1) | unprognostic (1.25e-1) | unprognostic (1.50e-1) | unprognostic (1.75e-1) | unprognostic (1.68e-1) | null | unprognostic (1.21e-2) |
FGR | c-fgr, p55c-fgr, SRC2 | ENSG00000000938 | FGR proto-oncogene, Src family tyrosine kinase | P09769 | 1 | 27612064-27635185 | Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins | Immunity, Innate immunity | Kinase, Transferase, Tyrosine-protein kinase | Proto-oncogene | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Group enriched | Detected in many | 6 | bone marrow: 205.7;lung: 83.9;lymphoid tissue: 137.8 | Cell type enhanced | Detected in many | null | Hofbauer cells: 117.4;Kupffer cells: 202.5;Langerhans cells: 79.5;Macrophages: 138.9;monocytes: 398.9;NK-cells: 135.9 | Group enriched | Detected in some | 12 | endothelial cell: 71.5;leukocyte: 85.8 | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Group enriched | Detected in some | 16 | Leukemia: 21.4;lymphoma: 33.4;Myeloma: 17.9 | Adipose subcutaneous - Macrophages, Adrenal gland - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Skin - Macrophages, Spleen - Neutrophils | Not detected | Not detected | null | null | Low region specificity | Detected in all | null | null | HPA002024 | Enhanced | null | Approved | Plasma membrane,Aggresome | null | null | null | null | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response | Cluster 47: Endothelial cells - Vasculature | Cluster 55: Lymphoma - Immune response | Cluster 29: Monocytes - Innate immune response | 16 | Plasma membrane | Aggresome | HPA002024: AB_1078503 | unprognostic (2.10e-3) | unprognostic (1.20e-2) | unprognostic (1.09e-5) | unprognostic (4.05e-2) | unprognostic (2.40e-1) | unprognostic (5.05e-2) | unprognostic (9.62e-4) | unprognostic (1.29e-1) | unprognostic (7.20e-2) | unprognostic (1.04e-1) | unprognostic (1.44e-2) | unprognostic (2.77e-1) | unprognostic (5.30e-2) | unprognostic (1.35e-2) | unprognostic (2.10e-1) | unprognostic (2.85e-2) | unprognostic (2.44e-3) | unprognostic (8.28e-2) | unprognostic (4.34e-1) | unprognostic (2.14e-1) | unprognostic (9.31e-2) | unprognostic (1.89e-2) | unprognostic (5.19e-3) | unprognostic (3.82e-2) | unprognostic (5.32e-4) | unprognostic (9.76e-3) | unprognostic (1.08e-1) | unprognostic (9.64e-2) | unprognostic (5.05e-2) | unprognostic (2.29e-1) | unprognostic (9.55e-2) |
CFH | ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS | ENSG00000000971 | Complement factor H | P08603 | 1 | 196651754-196752476 | Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins | Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity | null | Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Tissue enriched | Detected in all | 6 | liver: 1645.3 | Cell type enhanced | Detected in many | null | Fibroblasts: 355.9;Hepatocytes: 834.8;Leydig cells: 285.2;Mesothelial cells: 388.2;Ovarian stromal cells: 208.2 | Group enriched | Detected in many | 7 | endothelial cell: 317.6;fibroblast: 269.5;pericyte: 401.5;vascular associated smooth muscle cell: 148.7 | Cancer enriched | Detected in all | 9 | Liver Hepatocellular Carcinoma (TCGA): 468.2 | Region enhanced | Detected in all | null | choroid plexus: 43.6 | Immune cell enhanced | Detected in some | null | MAIT T-cell: 17.6 | Lineage enriched | Detected in single | 56 | T-cells: 17.6 | Cancer enhanced | Detected in many | null | Gallbladder cancer: 59.2 | Adrenal gland - Fibroblasts, Heart muscle - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblast_2 | null | null | null | null | null | null | null | null | CAB016385, CAB016769, HPA038922, HPA049176, HPA053326 | Supported | null | Approved | Vesicles | Secreted to blood | Immunity | null | null | 396,000,000,000 | 130,000,000,000 | Cluster 1: T-cells - Unknown function | Cluster 83: Liver - Metabolism | Cluster 42: Choroid plexus - Mitochondria | Cluster 71: Lymphoma - Inflammatory response | Cluster 53: Fibroblasts - ECM organization | 9 | Vesicles | null | CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113 | unprognostic (3.13e-1) | unprognostic (2.15e-1) | unprognostic (4.36e-1) | unprognostic (1.11e-1) | unprognostic (3.06e-1) | unprognostic (8.76e-2) | unprognostic (2.05e-3) | unprognostic (3.31e-4) | unprognostic (2.53e-1) | unprognostic (1.00e-1) | unprognostic (3.90e-3) | unprognostic (2.61e-2) | unprognostic (1.18e-1) | unprognostic (1.61e-3) | unprognostic (3.15e-3) | unprognostic (1.59e-1) | unprognostic (1.52e-2) | unprognostic (2.07e-1) | unprognostic (2.26e-2) | unprognostic (5.66e-2) | unprognostic (2.03e-2) | unprognostic (4.27e-2) | unprognostic (1.04e-1) | unprognostic (1.81e-1) | unprognostic (6.36e-2) | unprognostic (1.33e-1) | unprognostic (1.27e-2) | unprognostic (8.56e-3) | unprognostic (8.89e-3) | unprognostic (2.24e-1) | unprognostic (2.87e-2) |
FUCA2 | dJ20N2.5, MGC1314 | ENSG00000001036 | Alpha-L-fucosidase 2 | Q9BTY2 | 6 | 143494812-143511720 | Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins | null | Glycosidase, Hydrolase | null | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in all | null | parathyroid gland: 159.9 | Low cell type specificity | Detected in many | null | null | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Skin - Fibroblast_2, Spleen - Macrophages, Thyroid gland - Thyroid glandular cells | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA031659, HPA031661 | Approved | null | null | null | Secreted to blood | Enzyme | null | null | null | 86,000,000 | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 24: Parathyroid gland - Vesicular transport | Cluster 50: Non-specific - Nucleic acid binding | Cluster 28: Non-specific - Nuclear processes | Cluster 77: Plasma cells - Protein processing | 16 | null | null | HPA031659: AB_10600661, HPA031661: AB_10601681 | unprognostic (7.65e-2) | unprognostic (1.78e-3) | unprognostic (1.06e-2) | unprognostic (1.77e-2) | unprognostic (2.02e-2) | unprognostic (7.60e-3) | unprognostic (2.82e-2) | unprognostic (3.42e-4) | unprognostic (2.48e-2) | unprognostic (6.94e-3) | unprognostic (1.03e-4) | unprognostic (1.52e-1) | unprognostic (3.29e-2) | unprognostic (1.22e-10) | unprognostic (2.82e-8) | unprognostic (1.38e-5) | unprognostic (4.73e-2) | unprognostic (8.50e-2) | unprognostic (5.08e-3) | unprognostic (2.53e-3) | unprognostic (8.04e-2) | unprognostic (2.21e-1) | unprognostic (9.57e-2) | unprognostic (2.60e-1) | unprognostic (1.47e-1) | unprognostic (8.60e-3) | unprognostic (3.20e-1) | unprognostic (6.23e-2) | unprognostic (1.27e-1) | unprognostic (6.09e-2) | unprognostic (2.35e-2) |
GCLC | GCS, GLCL, GLCLC | ENSG00000001084 | Glutamate-cysteine ligase catalytic subunit | P48506 | 6 | 53497341-53616970 | Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins | Glutathione biosynthesis | Ligase | Disease variant, Hereditary hemolytic anemia | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in all | null | liver: 147.6 | Low cell type specificity | Detected in many | null | null | Low cell type specificity | Detected in all | null | null | Cancer enhanced | Detected in all | null | Lung Squamous Cell Carcinoma (TCGA): 133.6 | Low region specificity | Detected in all | null | null | Immune cell enhanced | Detected in many | null | NK-cell: 4.2 | Low lineage specificity | Detected in many | null | null | Cancer enhanced | Detected in all | null | Gallbladder cancer: 429.9 | Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Spleen - Macrophages | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | CAB009569, HPA036359, HPA036360 | Approved | null | Approved | Nucleoplasm,Nucleoli,Cytosol | null | null | null | null | null | 6,000,000 | Cluster 41: Basophils - Unknown function | Cluster 83: Liver - Metabolism | Cluster 13: Oligodendrocytes - Mixed function | Cluster 7: Liver cancer - Metabolism | Cluster 12: Squamous epithelial cells - Keratinization | 7 | Nucleoplasm | Nucleoli, Cytosol | CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789 | unprognostic (1.08e-1) | unprognostic (2.34e-2) | unprognostic (6.97e-2) | unprognostic (3.56e-3) | unprognostic (1.58e-1) | unprognostic (6.77e-2) | unprognostic (1.44e-1) | unprognostic (1.15e-1) | unprognostic (1.93e-1) | unprognostic (3.34e-2) | unprognostic (6.04e-8) | unprognostic (1.31e-3) | unprognostic (3.69e-3) | unprognostic (3.95e-1) | unprognostic (1.23e-1) | unprognostic (8.70e-4) | unprognostic (5.88e-2) | unprognostic (2.42e-1) | unprognostic (6.42e-2) | unprognostic (3.83e-1) | unprognostic (1.92e-1) | unprognostic (1.85e-1) | unprognostic (8.98e-2) | unprognostic (2.18e-2) | unprognostic (9.49e-4) | unprognostic (4.34e-1) | unprognostic (2.33e-3) | unprognostic (4.10e-1) | unprognostic (1.65e-1) | unprognostic (3.69e-2) | unprognostic (2.18e-1) |
NFYA | CBF-B, HAP2, NF-YA | ENSG00000001167 | Nuclear transcription factor Y subunit alpha | P23511 | 6 | 41072974-41102403 | Predicted intracellular proteins, Transcription factors | Biological rhythms, Transcription, Transcription regulation | Activator, DNA-binding | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in many | null | Early spermatids: 37.8;Late spermatids: 48.8 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Testis - Early spermatids | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | CAB009250, HPA050779 | Enhanced | null | Supported | Nucleoplasm | null | null | null | null | null | null | Cluster 33: Non-specific - ATP binding | Cluster 40: Non-specific - Transcription | Cluster 11: White matter - Signal transduction | Cluster 28: Non-specific - Nuclear processes | Cluster 63: Late spermatids - Spermatogenesis | 32 | Nucleoplasm | null | CAB009250: AB_2152107, HPA050779: AB_2681234 | unprognostic (8.42e-2) | unprognostic (2.79e-2) | unprognostic (2.71e-2) | unprognostic (4.04e-3) | unprognostic (4.07e-1) | unprognostic (1.42e-1) | unprognostic (4.75e-1) | unprognostic (2.37e-2) | unprognostic (3.49e-2) | unprognostic (5.15e-3) | unprognostic (5.08e-4) | unprognostic (7.41e-3) | unprognostic (3.83e-2) | unprognostic (1.68e-3) | unprognostic (1.39e-2) | unprognostic (1.83e-2) | unprognostic (7.19e-3) | unprognostic (3.32e-1) | unprognostic (8.77e-2) | unprognostic (2.18e-1) | unprognostic (1.05e-1) | unprognostic (3.61e-3) | unprognostic (1.13e-1) | unprognostic (3.23e-1) | unprognostic (9.49e-3) | unprognostic (1.59e-1) | unprognostic (3.51e-2) | unprognostic (3.57e-1) | unprognostic (1.46e-1) | unprognostic (3.53e-2) | unprognostic (6.11e-2) |
STPG1 | C1orf201, FLJ33340, MAPO2 | ENSG00000001460 | Sperm tail PG-rich repeat containing 1 | Q5TH74 | 1 | 24356999-24416934 | Predicted intracellular proteins | Apoptosis | null | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in all | null | testis: 26.7 | Group enriched | Detected in many | 13 | Early spermatids: 214.1;Late spermatids: 677.5 | Cell type enhanced | Detected in all | null | ependymal cell: 101.0 | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in some | null | null | Low lineage specificity | Detected in many | null | null | Low cancer specificity | Detected in all | null | null | Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids | Low region specificity | Detected in many | null | null | Low region specificity | Detected in many | null | null | HPA024301 | null | null | Approved | Nucleoplasm | null | null | null | null | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 8: Ciliated cells - Cilium organization | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 37: Non-specific - mRNA processing | Cluster 63: Late spermatids - Spermatogenesis | null | Nucleoplasm | null | HPA024301: AB_1845634 | unprognostic (4.58e-2) | unprognostic (3.44e-1) | null | unprognostic (1.35e-1) | unprognostic (2.48e-2) | unprognostic (1.79e-1) | unprognostic (5.99e-5) | null | unprognostic (7.83e-3) | unprognostic (2.52e-2) | unprognostic (1.12e-8) | unprognostic (1.99e-2) | unprognostic (1.67e-2) | unprognostic (2.89e-3) | null | unprognostic (4.01e-3) | unprognostic (1.67e-1) | unprognostic (1.19e-2) | unprognostic (1.89e-1) | unprognostic (1.85e-1) | unprognostic (2.57e-1) | unprognostic (3.50e-1) | unprognostic (1.54e-1) | unprognostic (3.39e-2) | unprognostic (3.81e-2) | unprognostic (1.24e-1) | unprognostic (2.06e-1) | unprognostic (5.50e-2) | unprognostic (1.34e-1) | unprognostic (4.45e-1) | unprognostic (5.63e-2) |
NIPAL3 | DJ462O23.2, NPAL3, SLC57A5 | ENSG00000001461 | NIPA like domain containing 3 | Q6P499 | 1 | 24415802-24472976 | Predicted intracellular proteins, Predicted membrane proteins, Transporters | null | null | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in all | null | brain: 65.3 | Cell type enhanced | Detected in all | null | Cone photoreceptor cells: 98.6;Oligodendrocytes: 85.5;Prostatic glandular cells: 192.0 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Adrenal gland - Adrenal cortex cells, Colon - Smooth muscle cells, Prostate - Prostate glandular cells, Testis - Sertoli cells, Thyroid gland - Thyroid glandular cells | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA039978 | Approved | null | Approved | Nucleoplasm | null | null | null | null | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 9: Oligodendrocytes - Myelination | Cluster 26: Oligodendrocytes - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 40: Prostatic glandular cells - Transcription | 8 | Nucleoplasm | null | HPA039978: AB_10697712 | unprognostic (2.29e-1) | unprognostic (1.46e-1) | unprognostic (6.19e-2) | unprognostic (2.88e-3) | unprognostic (1.76e-2) | unprognostic (1.03e-1) | unprognostic (6.52e-2) | unprognostic (2.43e-2) | unprognostic (7.61e-2) | unprognostic (1.99e-2) | unprognostic (1.35e-9) | unprognostic (3.24e-3) | unprognostic (1.25e-2) | unprognostic (8.50e-5) | unprognostic (1.15e-1) | unprognostic (6.18e-2) | unprognostic (1.10e-1) | unprognostic (2.17e-1) | unprognostic (3.41e-2) | unprognostic (9.12e-2) | unprognostic (7.92e-2) | unprognostic (6.60e-2) | unprognostic (1.08e-4) | unprognostic (2.17e-1) | unprognostic (8.50e-2) | unprognostic (4.05e-2) | unprognostic (3.85e-1) | unprognostic (3.08e-2) | unprognostic (1.82e-1) | unprognostic (2.38e-2) | unprognostic (1.61e-2) |
LAS1L | FLJ12525, Las1 | ENSG00000001497 | LAS1 like ribosome biogenesis factor | Q9Y4W2 | X | 65438549-65534810 | Disease related genes, Human disease related genes, Predicted intracellular proteins | rRNA processing | Hydrolase | Disease variant, Intellectual disability, Obesity | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in all | null | Late spermatids: 143.1 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Testis - Sertoli cells | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA044431, HPA061463 | Supported | null | Uncertain | Nucleoplasm,Centriolar satellite,Cytosol | null | null | null | null | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 66: Non-specific - Transcription | Cluster 13: Oligodendrocytes - Mixed function | Cluster 36: Non-specific - mRNA processing | Cluster 63: Late spermatids - Spermatogenesis | 51 | Nucleoplasm | Centriolar satellite, Cytosol | HPA044431: AB_10965695, HPA061463: AB_2684530 | unprognostic (1.42e-1) | unprognostic (3.99e-3) | unprognostic (1.49e-1) | unprognostic (1.80e-3) | unprognostic (2.24e-1) | unprognostic (4.98e-2) | unprognostic (5.11e-1) | unprognostic (4.67e-3) | unprognostic (6.80e-3) | unprognostic (5.41e-2) | unprognostic (1.15e-3) | unprognostic (7.75e-2) | unprognostic (5.08e-2) | unprognostic (1.99e-2) | unprognostic (3.52e-4) | unprognostic (3.01e-2) | unprognostic (2.88e-3) | unprognostic (5.13e-2) | unprognostic (1.66e-1) | unprognostic (1.40e-1) | unprognostic (2.56e-2) | unprognostic (2.64e-2) | unprognostic (5.67e-3) | unprognostic (4.29e-2) | unprognostic (2.84e-1) | unprognostic (8.22e-2) | unprognostic (1.30e-1) | unprognostic (9.82e-2) | unprognostic (7.60e-4) | unprognostic (1.99e-2) | unprognostic (3.23e-2) |
ENPP4 | AP3Aase, KIAA0879, NPP4 | ENSG00000001561 | Ectonucleotide pyrophosphatase/phosphodiesterase 4 | Q9Y6X5 | 6 | 46129989-46146688 | Enzymes, Predicted membrane proteins | Blood coagulation, Hemostasis | Hydrolase | null | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in many | null | Basal prostatic cells: 95.2;dendritic cells: 70.1;Oligodendrocytes: 116.7 | Cell type enhanced | Detected in all | null | oligodendrocyte: 134.6 | Low cancer specificity | Detected in many | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in many | null | null | Low lineage specificity | Detected in many | null | null | Low cancer specificity | Detected in many | null | null | Breast - Endothelial cells | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA016594 | Approved | null | null | null | null | null | null | null | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 9: Oligodendrocytes - Myelination | Cluster 28: Oligodendrocytes - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 3: Basal prostatic cells - Lipid metabolism | 10 | null | null | HPA016594: AB_1848171 | unprognostic (5.85e-3) | unprognostic (3.15e-2) | unprognostic (1.14e-1) | unprognostic (2.42e-2) | unprognostic (4.22e-2) | unprognostic (6.22e-2) | unprognostic (3.13e-1) | unprognostic (3.85e-2) | unprognostic (1.48e-1) | unprognostic (1.79e-1) | unprognostic (9.35e-9) | unprognostic (7.29e-4) | unprognostic (6.11e-2) | unprognostic (9.29e-2) | unprognostic (7.56e-2) | unprognostic (6.89e-3) | unprognostic (4.05e-2) | unprognostic (3.49e-4) | unprognostic (2.75e-2) | unprognostic (1.77e-1) | unprognostic (3.70e-3) | unprognostic (3.08e-1) | unprognostic (2.22e-2) | unprognostic (2.51e-1) | unprognostic (1.08e-1) | unprognostic (3.08e-3) | null | unprognostic (1.05e-1) | unprognostic (1.99e-1) | unprognostic (3.58e-2) | unprognostic (1.19e-1) |
SEMA3F | Sema4, SEMAK | ENSG00000001617 | Semaphorin 3F | Q13275 | 3 | 50155045-50189075 | Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins | null | null | null | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | Tissue enhanced | Detected in all | null | esophagus: 97.9 | Cell type enhanced | Detected in many | null | Adipocytes: 38.2;Basal prostatic cells: 33.1;Bipolar cells: 23.9;Endothelial cells: 26.5;Suprabasal keratinocytes: 34.7 | Cell type enhanced | Detected in many | null | endothelial cell: 28.8 | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Not detected in immune cells | Not detected | null | null | Not detected | Not detected | null | null | Cancer enhanced | Detected in all | null | Gallbladder cancer: 84.1 | Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Pituitary gland - Endothelial cells, Skin - Keratinocyte (other) | Low region specificity | Detected in all | null | null | Low region specificity | Detected in many | null | null | HPA035008 | Approved | null | null | null | Secreted to blood | Developmental protein | null | null | 1,700,000 | 7,000,000 | null | Cluster 27: Squamous epithelium - Keratinization | Cluster 38: Sub-cortical - Mixed function | Cluster 48: Adipocytes & Endothelial cells - Angiogenesis | Cluster 12: Squamous epithelial cells - Keratinization | null | null | null | HPA035008: AB_10604091 | unprognostic (5.00e-2) | unprognostic (2.59e-1) | unprognostic (1.13e-1) | unprognostic (1.75e-1) | unprognostic (1.99e-1) | unprognostic (1.33e-2) | unprognostic (2.23e-3) | unprognostic (1.99e-2) | unprognostic (2.34e-1) | unprognostic (2.50e-1) | unprognostic (8.31e-7) | unprognostic (3.53e-3) | unprognostic (2.38e-1) | unprognostic (2.74e-4) | unprognostic (9.23e-3) | unprognostic (2.30e-2) | unprognostic (7.06e-3) | unprognostic (1.45e-1) | unprognostic (2.56e-1) | unprognostic (8.53e-2) | unprognostic (2.52e-1) | unprognostic (6.67e-3) | unprognostic (2.58e-1) | unprognostic (7.71e-2) | unprognostic (3.61e-2) | unprognostic (2.36e-1) | unprognostic (1.08e-1) | unprognostic (1.26e-1) | unprognostic (1.26e-1) | unprognostic (2.20e-2) | unprognostic (1.66e-1) |
CFTR | ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR | ENSG00000001626 | CF transmembrane conductance regulator | P13569 | 7 | 117287120-117715971 | Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters | Ion transport, Transport | Chloride channel, Ion channel, Isomerase | Cancer-related genes, Disease variant, FDA approved drug targets | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in many | null | gallbladder: 48.4;intestine: 43.6;pancreas: 192.0 | Group enriched | Detected in many | 4 | Ductal cells: 590.0;Late spermatids: 149.9 | Cell type enhanced | Detected in many | null | oligodendrocyte: 247.2 | Group enriched | Detected in many | 4 | Colon Adenocarcinoma (TCGA): 35.0;Kidney Chromophobe (TCGA): 72.6;Pancreatic Adenocarcinoma (TCGA): 35.8;Rectum Adenocarcinoma (TCGA): 36.5 | Low region specificity | Detected in many | null | null | Not detected in immune cells | Not detected | null | null | Not detected | Not detected | null | null | Cancer enhanced | Detected in many | null | colorectal cancer: 24.2;Gastric cancer: 9.6 | Adipose visceral - Mesothelial cells, Breast - Breast glandular cells, Colon - Colon enterocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Skin - Eccrine sweat gland cells | Low region specificity | Detected in single | null | null | Low region specificity | Detected in all | null | null | CAB001951, HPA021939, HPA079652 | Enhanced | null | null | null | null | null | null | null | null | null | null | Cluster 15: Pancreas - Proteolysis | Cluster 11: White matter - Signal transduction | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 45: Non-specific - Mixed function | 372 | null | null | CAB001951: , HPA021939: AB_1846578, HPA079652: | null | null | unprognostic (2.40e-1) | unprognostic (2.21e-1) | unprognostic (1.25e-2) | unprognostic (2.36e-4) | null | null | null | unprognostic (5.50e-3) | unprognostic (7.23e-3) | null | unprognostic (6.53e-2) | unprognostic (5.71e-2) | unprognostic (5.84e-2) | unprognostic (3.02e-4) | unprognostic (4.86e-1) | unprognostic (3.43e-2) | unprognostic (1.93e-1) | unprognostic (1.97e-1) | unprognostic (2.56e-2) | unprognostic (2.29e-2) | unprognostic (7.79e-2) | unprognostic (6.28e-2) | unprognostic (5.19e-3) | unprognostic (2.45e-1) | null | unprognostic (1.32e-1) | unprognostic (2.58e-1) | null | unprognostic (1.67e-3) |
ANKIB1 | DKFZP434A0225, KIAA1386 | ENSG00000001629 | Ankyrin repeat and IBR domain containing 1 | Q9P2G1 | 7 | 92245974-92401383 | Enzymes, Predicted intracellular proteins | Ubl conjugation pathway | Transferase | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in all | null | Excitatory neurons: 176.4;Inhibitory neurons: 209.0;Oligodendrocyte precursor cells: 165.6;Oligodendrocytes: 549.9 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in many | null | null | Low lineage specificity | Detected in many | null | null | Low cancer specificity | Detected in all | null | null | Adrenal gland - Adrenal cortex cells, Testis - Spermatocytes | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA019358, HPA021780 | Uncertain | null | Supported | Plasma membrane,Cytosol | null | null | null | null | null | null | Cluster 14: Non-specific - Unknown function | Cluster 61: Brain - Neuronal signaling | Cluster 13: Oligodendrocytes - Mixed function | Cluster 39: Non-specific - Transcription | Cluster 51: Oligodendrocytes - Unknown function | 2 | Plasma membrane, Cytosol | null | HPA019358: AB_1844831, HPA021780: AB_2670819 | unprognostic (3.63e-2) | unprognostic (3.94e-2) | unprognostic (1.28e-1) | unprognostic (2.05e-3) | unprognostic (4.01e-1) | unprognostic (2.57e-1) | unprognostic (3.65e-1) | unprognostic (1.54e-1) | unprognostic (1.26e-1) | unprognostic (2.96e-6) | unprognostic (3.92e-6) | unprognostic (1.29e-1) | unprognostic (6.10e-2) | unprognostic (1.60e-4) | unprognostic (6.43e-2) | unprognostic (3.18e-2) | unprognostic (4.19e-2) | unprognostic (5.18e-2) | unprognostic (3.94e-1) | unprognostic (1.52e-1) | unprognostic (1.94e-2) | unprognostic (1.11e-3) | unprognostic (7.77e-2) | unprognostic (4.40e-2) | unprognostic (5.97e-3) | unprognostic (1.31e-1) | unprognostic (1.14e-1) | unprognostic (6.26e-3) | unprognostic (2.89e-1) | unprognostic (4.55e-2) | unprognostic (1.67e-1) |
CYP51A1 | CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1 | ENSG00000001630 | Cytochrome P450 family 51 subfamily A member 1 | Q16850 | 7 | 92084987-92134803 | Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins | Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism | Monooxygenase, Oxidoreductase | FDA approved drug targets | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in all | null | liver: 196.0 | Cell type enhanced | Detected in many | null | Early spermatids: 52.6;Kupffer cells: 56.0;Oligodendrocytes: 49.4;Squamous epithelial cells: 50.2 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Colon - Macrophages, Liver - Hepatocytes, Lung - Alveolar cells type 2, Testis - Early spermatids, Testis - Late spermatids | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA041325, HPA043508 | Approved | null | Approved | Endoplasmic reticulum | null | null | null | null | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 69: Liver - Oxidoreductase activity | Cluster 49: Hindbrain - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 62: Hepatocytes - Metabolism | 12 | Endoplasmic reticulum | null | HPA041325: AB_2677411, HPA043508: AB_2678520 | unprognostic (2.56e-2) | unprognostic (1.94e-1) | unprognostic (9.05e-2) | unprognostic (2.32e-4) | unprognostic (2.91e-3) | unprognostic (1.54e-1) | unprognostic (1.62e-1) | unprognostic (1.64e-3) | unprognostic (7.22e-4) | unprognostic (7.26e-4) | unprognostic (2.27e-9) | unprognostic (6.45e-2) | unprognostic (3.14e-1) | unprognostic (1.25e-1) | unprognostic (6.25e-2) | unprognostic (3.93e-2) | unprognostic (2.40e-1) | unprognostic (2.27e-1) | unprognostic (2.67e-2) | unprognostic (3.09e-1) | unprognostic (2.54e-1) | unprognostic (1.12e-1) | unprognostic (5.56e-2) | unprognostic (3.83e-2) | unprognostic (6.86e-2) | unprognostic (1.05e-1) | unprognostic (1.49e-1) | unprognostic (1.14e-1) | unprognostic (3.85e-1) | unprognostic (4.24e-2) | unprognostic (4.72e-2) |
KRIT1 | CAM, CCM1 | ENSG00000001631 | KRIT1 ankyrin repeat containing | O00522 | 7 | 92197498-92246166 | Disease related genes, Human disease related genes, Predicted intracellular proteins | Angiogenesis | null | Disease variant | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in all | null | Inhibitory neurons: 88.8;Oligodendrocytes: 107.4 | Low cell type specificity | Detected in many | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Testis - Spermatocytes | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA049606 | Supported | null | Uncertain | Vesicles | null | null | null | null | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 51: Thyroid gland - Unknown function | Cluster 55: Non-specific - Transcription | Cluster 39: Non-specific - Transcription | Cluster 49: Non-specific - Transcription | 13 | Vesicles | null | HPA049606: AB_2680832 | unprognostic (1.91e-1) | unprognostic (1.03e-1) | unprognostic (1.72e-2) | unprognostic (3.65e-2) | unprognostic (4.37e-2) | unprognostic (2.32e-2) | unprognostic (4.30e-1) | unprognostic (9.86e-3) | unprognostic (3.80e-2) | unprognostic (4.13e-4) | unprognostic (1.96e-6) | unprognostic (2.28e-3) | unprognostic (1.81e-1) | unprognostic (3.74e-3) | unprognostic (2.24e-1) | unprognostic (3.02e-1) | unprognostic (2.04e-1) | unprognostic (2.52e-2) | unprognostic (1.39e-1) | unprognostic (3.11e-2) | unprognostic (1.19e-1) | unprognostic (1.07e-1) | unprognostic (2.89e-1) | unprognostic (1.21e-1) | unprognostic (1.01e-2) | unprognostic (1.77e-1) | unprognostic (9.49e-2) | unprognostic (7.34e-2) | unprognostic (3.28e-1) | unprognostic (5.63e-2) | unprognostic (1.67e-1) |
RAD52 | null | ENSG00000002016 | RAD52 homolog, DNA repair protein | P43351 | 12 | 911736-990053 | Cancer-related genes, Predicted intracellular proteins | DNA damage, DNA recombination, DNA repair | DNA-binding | Cancer-related genes | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Group enriched | Detected in many | 4 | Astrocytes: 33.1;Excitatory neurons: 36.7;Inhibitory neurons: 46.8;Microglial cells: 22.4;Oligodendrocyte precursor cells: 28.3;Oligodendrocytes: 50.8 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | null | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA028957 | null | null | Approved | Nuclear speckles,Plasma membrane | null | null | null | null | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 19: Non-specific - Basic cellular processes | Cluster 11: White matter - Signal transduction | Cluster 38: Non-specific - Transcription | Cluster 8: Neurons - Neuronal signaling | 23 | Nuclear speckles | Plasma membrane | HPA028957: AB_2672842 | unprognostic (1.35e-1) | unprognostic (5.29e-2) | unprognostic (3.23e-1) | unprognostic (1.72e-2) | unprognostic (1.69e-1) | unprognostic (1.18e-1) | unprognostic (4.94e-2) | unprognostic (9.70e-3) | unprognostic (1.75e-1) | unprognostic (6.18e-5) | unprognostic (3.05e-3) | unprognostic (3.09e-2) | unprognostic (2.70e-1) | unprognostic (2.01e-3) | unprognostic (3.94e-2) | unprognostic (1.39e-1) | unprognostic (7.56e-2) | unprognostic (2.53e-2) | unprognostic (1.27e-1) | unprognostic (1.01e-1) | unprognostic (6.98e-2) | unprognostic (4.41e-3) | unprognostic (1.81e-2) | unprognostic (3.51e-1) | unprognostic (9.94e-4) | unprognostic (3.91e-1) | unprognostic (1.00e-1) | unprognostic (5.35e-2) | unprognostic (5.06e-1) | unprognostic (8.91e-2) | unprognostic (1.89e-1) |
BAD | BBC2, BCL2L8 | ENSG00000002330 | BCL2 associated agonist of cell death | Q92934 | 11 | 64269830-64284704 | Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins | Apoptosis | null | Cancer-related genes | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Low cell type specificity | Detected in all | null | null | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | null | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | CAB004205, HPA028185, HPA062105 | Approved | null | Enhanced | Mitochondria,Mid piece,Principal piece,End piece | null | null | null | null | null | null | Cluster 29: Non-specific - Unknown function | Cluster 43: Non-specific - Mitochondrial translation | Cluster 27: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 5: Enterocytes - Absorption | 44 | Mitochondria | Mid piece, Principal piece, End piece | CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684 | unprognostic (1.86e-1) | unprognostic (2.17e-1) | unprognostic (9.12e-3) | unprognostic (7.87e-2) | unprognostic (6.68e-2) | unprognostic (2.76e-1) | unprognostic (1.27e-1) | unprognostic (8.77e-2) | unprognostic (7.89e-2) | unprognostic (1.08e-2) | unprognostic (1.11e-1) | unprognostic (1.18e-2) | unprognostic (3.69e-2) | unprognostic (4.49e-4) | unprognostic (1.65e-1) | unprognostic (4.51e-2) | unprognostic (1.06e-1) | unprognostic (4.44e-2) | unprognostic (4.74e-1) | unprognostic (1.95e-1) | unprognostic (2.37e-1) | unprognostic (1.42e-1) | unprognostic (4.78e-4) | unprognostic (1.24e-1) | unprognostic (2.52e-1) | unprognostic (3.25e-1) | unprognostic (7.57e-2) | unprognostic (1.45e-1) | unprognostic (1.13e-1) | unprognostic (2.27e-1) | unprognostic (3.05e-1) |
LAP3 | LAP, LAPEP, PEPS | ENSG00000002549 | Leucine aminopeptidase 3 | P28838 | 4 | 17577198-17607972 | Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins | null | Aminopeptidase, Hydrolase, Protease | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in all | null | Hofbauer cells: 264.8;Proximal tubular cells: 263.7 | Cell type enhanced | Detected in all | null | endothelial cell: 82.6 | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | null | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA029606, HPA029607 | Enhanced | null | Approved | Nucleoplasm,Midbody,Cytosol,Calyx,Mid piece,Principal piece | null | null | Yes | No | null | 5,000,000 | Cluster 10: Non-specific - Membrane trafficking | Cluster 70: Lymphoid tissue - Immune response | Cluster 19: Astrocytes - Mixed function | Cluster 31: Non-specific - Antiviral immune response | Cluster 41: Adipocytes & Endothelial cells - Mixed function | 15 | Cytosol | Nucleoplasm, Midbody, Calyx, Mid piece, Principal piece | HPA029606: AB_10599288, HPA029607: AB_10611381 | unprognostic (6.83e-2) | unprognostic (3.01e-1) | unprognostic (1.42e-2) | unprognostic (8.58e-2) | unprognostic (3.35e-2) | unprognostic (1.19e-1) | unprognostic (7.13e-2) | unprognostic (2.42e-1) | unprognostic (3.03e-1) | unprognostic (2.79e-1) | unprognostic (6.48e-5) | unprognostic (2.87e-2) | unprognostic (1.31e-2) | unprognostic (7.91e-2) | unprognostic (8.29e-2) | unprognostic (5.58e-2) | unprognostic (3.31e-2) | unprognostic (1.04e-2) | unprognostic (3.46e-1) | unprognostic (1.11e-1) | unprognostic (4.17e-2) | unprognostic (1.08e-2) | unprognostic (1.24e-1) | unprognostic (2.11e-1) | unprognostic (8.87e-2) | unprognostic (5.10e-2) | unprognostic (4.00e-2) | unprognostic (9.97e-2) | unprognostic (5.68e-3) | unprognostic (3.55e-1) | unprognostic (4.35e-1) |
CD99 | MIC2 | ENSG00000002586 | CD99 molecule (Xg blood group) | P14209 | X | 2691187-2741309 | CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins | Cell adhesion | null | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Low cell type specificity | Detected in many | null | null | Cell type enhanced | Detected in some | null | ependymal cell: 6.5;leukocyte: 5.7;pericyte: 7.7 | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Skin - Fibroblast_1, Skin - Fibroblast_2 | null | null | null | null | Low region specificity | Detected in all | null | null | CAB000020, HPA035304 | Supported | null | Approved | Golgi apparatus | null | null | null | null | null | 64,000,000 | Cluster 13: Non-specific - Mitochondria | Cluster 41: Smooth muscle tissue - ECM organization | Cluster 39: Astrocytes - Mixed function | Cluster 12: Bone cancer - Neuronal signaling | Cluster 53: Fibroblasts - ECM organization | 3 | Golgi apparatus | null | CAB000020: AB_2076419, HPA035304: AB_10672861 | unprognostic (3.46e-1) | unprognostic (1.46e-2) | unprognostic (3.51e-2) | unprognostic (1.62e-1) | unprognostic (2.98e-2) | unprognostic (3.47e-2) | unprognostic (3.56e-2) | null | unprognostic (5.61e-2) | unprognostic (4.04e-2) | unprognostic (6.99e-2) | unprognostic (2.45e-1) | unprognostic (8.18e-2) | unprognostic (2.31e-3) | null | unprognostic (1.13e-4) | unprognostic (2.06e-4) | unprognostic (1.39e-1) | unprognostic (3.68e-2) | unprognostic (4.27e-1) | unprognostic (2.23e-1) | unprognostic (4.12e-2) | unprognostic (4.41e-3) | unprognostic (1.69e-1) | unprognostic (2.22e-1) | unprognostic (4.33e-2) | unprognostic (3.05e-2) | unprognostic (7.86e-3) | unprognostic (7.75e-2) | unprognostic (1.30e-2) | unprognostic (5.70e-2) |
HS3ST1 | 3OST1 | ENSG00000002587 | Heparan sulfate-glucosamine 3-sulfotransferase 1 | O14792 | 4 | 11393150-11429564 | Enzymes, Metabolic proteins, Predicted intracellular proteins | null | Transferase | null | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in many | null | ovary: 30.9 | Cell type enhanced | Detected in many | null | Granulosa cells: 147.6;Ionocytes: 127.4;Lymphatic endothelial cells: 98.3;Ovarian stromal cells: 172.3;Peritubular cells: 88.0 | Cell type enhanced | Detected in many | null | upper rhombic lip: 122.7 | Low cancer specificity | Detected in many | null | null | Low region specificity | Detected in all | null | null | Group enriched | Detected in some | 36 | memory B-cell: 15.0;naive B-cell: 26.7;plasmacytoid DC: 42.5 | Group enriched | Detected in many | 110 | B-cells: 26.7;dendritic cells: 42.5 | Cancer enhanced | Detected in many | null | pancreatic cancer: 29.8 | Prostate - Endothelial cells | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA002237 | Approved | null | Approved | Vesicles | Intracellular and membrane | Enzyme | null | null | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 64: Neuronal - Transcription | Cluster 35: Non-specific - DNA binding | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 6: Ovarian stromal cells - Transcription | 28 | Vesicles | null | HPA002237: AB_1079085 | unprognostic (1.63e-2) | unprognostic (1.88e-2) | unprognostic (7.69e-2) | unprognostic (1.77e-2) | unprognostic (3.47e-2) | unprognostic (2.20e-1) | unprognostic (1.05e-1) | unprognostic (2.44e-2) | unprognostic (1.47e-2) | unprognostic (1.52e-1) | unprognostic (6.69e-7) | unprognostic (2.72e-1) | unprognostic (6.60e-2) | null | unprognostic (6.06e-2) | unprognostic (1.78e-1) | unprognostic (4.93e-2) | unprognostic (8.28e-2) | unprognostic (2.75e-1) | unprognostic (3.49e-2) | unprognostic (5.31e-2) | unprognostic (3.83e-2) | unprognostic (2.37e-1) | unprognostic (6.00e-2) | unprognostic (4.33e-2) | unprognostic (7.61e-2) | unprognostic (1.90e-2) | unprognostic (1.62e-2) | unprognostic (1.86e-1) | unprognostic (7.93e-2) | unprognostic (1.00e-1) |
AOC1 | ABP, ABP1, DAO | ENSG00000002726 | Amine oxidase copper containing 1 | P19801 | 7 | 150824627-150861504 | Enzymes, Metabolic proteins, Predicted secreted proteins | null | Heparin-binding, Oxidoreductase | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Group enriched | Detected in many | 16 | intestine: 221.1;kidney: 131.7;placenta: 479.6 | Cell type enhanced | Detected in many | null | Collecting duct cells: 241.2;Distal enterocytes: 377.7;Intestinal goblet cells: 116.8;Paneth cells: 304.1;Proximal enterocytes: 876.3 | Group enriched | Detected in some | 4 | ependymal cell: 3.5;midbrain-derived inhibitory: 2.6 | Cancer enhanced | Detected in many | null | Kidney Renal Clear Cell Carcinoma (TCGA): 141.2 | Low region specificity | Detected in all | null | null | Immune cell enriched | Detected in some | 12 | eosinophil: 31.3 | Lineage enriched | Detected in many | 22 | granulocytes: 31.3 | Cancer enhanced | Detected in many | null | colorectal cancer: 48.4 | Colon - Colon enterocytes | Not detected | Not detected | null | null | Not detected | Not detected | null | null | HPA031032, HPA031033 | Approved | null | null | null | Secreted in other tissues | Enzyme | null | null | null | 33,000,000 | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 45: Intestine - Digestion | Cluster 46: Brainstem - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 5: Enterocytes - Absorption | 8 | null | null | HPA031032: AB_10670150, HPA031033: AB_10669670 | unprognostic (2.72e-2) | unprognostic (2.10e-2) | null | unprognostic (7.24e-2) | unprognostic (1.10e-2) | unprognostic (1.33e-1) | null | null | unprognostic (3.32e-2) | unprognostic (6.01e-2) | unprognostic (1.36e-6) | unprognostic (1.03e-3) | unprognostic (1.03e-2) | unprognostic (4.78e-3) | null | unprognostic (1.06e-1) | unprognostic (2.23e-1) | unprognostic (2.76e-3) | unprognostic (1.00e-1) | unprognostic (2.30e-1) | unprognostic (2.66e-2) | unprognostic (1.10e-1) | unprognostic (4.03e-3) | unprognostic (7.64e-3) | unprognostic (3.12e-2) | unprognostic (5.26e-3) | null | unprognostic (9.01e-2) | unprognostic (2.71e-2) | unprognostic (2.02e-1) | unprognostic (1.01e-3) |
WNT16 | null | ENSG00000002745 | Wnt family member 16 | Q9UBV4 | 7 | 121325367-121341104 | Predicted intracellular proteins, Predicted secreted proteins | Wnt signaling pathway | Developmental protein | null | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | Group enriched | Detected in some | 4 | cervix: 5.8;skin 1: 20.0 | Cell type enhanced | Detected in some | null | B-cells: 3.8;Basal keratinocytes: 6.0;Endometrial stromal cells: 3.3;Inhibitory neurons: 5.8;Microglial cells: 3.6;Suprabasal keratinocytes: 6.3 | Group enriched | Detected in some | 4 | ependymal cell: 9.1;fibroblast: 18.1;LAMP5-LHX6 and Chandelier: 9.4;MGE interneuron: 23.1 | Low cancer specificity | Detected in some | null | null | Low region specificity | Detected in many | null | null | Group enriched | Detected in some | 145 | memory B-cell: 15.6;naive B-cell: 15.5 | Lineage enriched | Detected in single | 146 | B-cells: 15.6 | Cancer enhanced | Detected in many | null | Leukemia: 9.8 | Colon - Enteric glia cells, Spleen - B-cells (Spleen) | Low region specificity | Detected in single | null | null | Low region specificity | Detected in all | null | null | null | null | null | null | null | Secreted to extracellular matrix | Developmental protein | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 13: Skin - Cornification | Cluster 23: Choroid plexus - Mixed function | Cluster 6: Leukemia - Signal transduction | Cluster 8: Neurons - Neuronal signaling | null | null | null | null | null | null | unprognostic (8.22e-2) | null | null | null | unprognostic (1.42e-3) | null | null | null | null | null | null | null | null | unprognostic (5.54e-3) | null | unprognostic (3.03e-1) | null | null | null | null | null | null | null | null | null | null | null | null | null |
HECW1 | KIAA0322, NEDL1 | ENSG00000002746 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 | Q76N89 | 7 | 43112629-43566001 | Enzymes, Metabolic proteins, Predicted intracellular proteins | Ubl conjugation pathway | Transferase | null | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | Tissue enhanced | Detected in some | null | brain: 8.0;kidney: 7.5 | Cell type enhanced | Detected in some | null | Early spermatids: 131.2;Excitatory neurons: 515.5;Inhibitory neurons: 151.1;Late spermatids: 78.2;Oligodendrocyte precursor cells: 260.8 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in many | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in some | null | null | Low lineage specificity | Detected in single | null | null | Low cancer specificity | Detected in many | null | null | Breast - Fibroblasts, Kidney - Proximal tubular cells, Testis - Early spermatids, Testis - Late spermatids | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA007203, HPA007593, HPA007609 | Uncertain | null | Approved | Nucleoli fibrillar center,Cytosol | null | null | null | null | null | null | Cluster 20: Non-specific - DNA binding | Cluster 61: Brain - Neuronal signaling | Cluster 14: Neurons - Synaptic function | Cluster 7: Liver cancer - Metabolism | Cluster 34: Neurons - Neuronal signaling | 6 | Nucleoli fibrillar center | Cytosol | HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518 | unprognostic (8.99e-2) | null | unprognostic (2.98e-1) | unprognostic (6.83e-4) | unprognostic (1.19e-3) | unprognostic (3.57e-2) | unprognostic (2.50e-1) | null | unprognostic (1.61e-1) | null | unprognostic (2.77e-3) | null | unprognostic (3.26e-2) | null | null | unprognostic (1.26e-1) | null | unprognostic (2.83e-1) | null | null | null | unprognostic (5.45e-2) | unprognostic (7.64e-2) | unprognostic (2.72e-1) | null | unprognostic (2.24e-2) | null | unprognostic (1.66e-1) | unprognostic (3.31e-1) | null | unprognostic (1.97e-2) |
MAD1L1 | HsMAD1, MAD1, PIG9, TP53I9, TXBP181 | ENSG00000002822 | Mitotic arrest deficient 1 like 1 | Q9Y6D9 | 7 | 1815793-2233243 | Disease related genes, Human disease related genes, Predicted intracellular proteins | Cell cycle, Cell division, Mitosis | null | Disease variant | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in many | null | Early spermatids: 28.1;Excitatory neurons: 20.2;Inhibitory neurons: 23.3;Late spermatids: 59.1;Microglial cells: 20.6;Oligodendrocytes: 30.2 | Low cell type specificity | Detected in all | null | null | Cancer enhanced | Detected in all | null | Skin Cuteneous Melanoma (TCGA): 93.8 | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Testis - Early spermatids, Testis - Late spermatids | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA003635, CAB015338 | Supported | null | Supported | Nucleoplasm,Nuclear membrane | null | null | null | null | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 70: Lymphoid tissue - Immune response | Cluster 11: White matter - Signal transduction | Cluster 67: Non-specific - Unknown function | Cluster 7: T-cells - T-cell receptor | 61 | Nucleoplasm, Nuclear membrane | null | CAB015338: AB_627901, HPA003635: AB_1853472 | unprognostic (1.28e-1) | unprognostic (1.64e-1) | unprognostic (2.37e-1) | unprognostic (3.34e-1) | unprognostic (1.85e-2) | unprognostic (7.03e-2) | unprognostic (1.08e-1) | unprognostic (1.97e-2) | unprognostic (5.34e-2) | unprognostic (1.44e-1) | unprognostic (3.78e-2) | unprognostic (1.01e-1) | unprognostic (8.39e-4) | unprognostic (1.86e-4) | unprognostic (3.70e-2) | unprognostic (2.46e-2) | unprognostic (4.94e-2) | unprognostic (9.24e-2) | unprognostic (1.46e-1) | unprognostic (2.21e-3) | unprognostic (1.05e-1) | unprognostic (1.61e-1) | unprognostic (5.09e-4) | unprognostic (7.47e-2) | unprognostic (1.61e-1) | unprognostic (6.41e-2) | unprognostic (3.20e-2) | unprognostic (2.03e-1) | unprognostic (2.36e-2) | unprognostic (1.14e-1) | unprognostic (3.76e-1) |
LASP1 | Lasp-1, MLN50 | ENSG00000002834 | LIM and SH3 protein 1 | Q14847 | 17 | 38869859-38921770 | Cancer-related genes, Plasma proteins, Predicted intracellular proteins | Ion transport, Transport | Actin-binding | Cancer-related genes | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in all | null | Late spermatids: 588.6;Proximal enterocytes: 277.0 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Spleen - Fibroblast_1 | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA012072, CAB022049 | Enhanced | null | Supported | Plasma membrane,Focal adhesion sites,Cytosol | null | null | null | null | null | 14,000,000 | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 25: Small intestine - Absorption | Cluster 38: Sub-cortical - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 36: Late spermatids - Unknown function | 35 | Plasma membrane, Cytosol | Focal adhesion sites | CAB022049: , HPA012072: AB_1852714 | unprognostic (8.07e-2) | unprognostic (3.35e-1) | unprognostic (5.77e-2) | unprognostic (9.20e-4) | unprognostic (3.18e-1) | unprognostic (1.48e-1) | unprognostic (2.52e-1) | unprognostic (8.20e-2) | unprognostic (1.49e-1) | unprognostic (4.68e-2) | unprognostic (5.01e-5) | unprognostic (9.04e-2) | unprognostic (3.62e-1) | unprognostic (8.54e-4) | unprognostic (9.46e-3) | unprognostic (2.53e-4) | unprognostic (9.54e-3) | unprognostic (8.17e-3) | unprognostic (2.25e-1) | unprognostic (2.63e-2) | unprognostic (1.46e-1) | unprognostic (4.16e-2) | unprognostic (1.19e-1) | unprognostic (1.41e-1) | unprognostic (6.40e-2) | unprognostic (1.49e-1) | unprognostic (6.83e-2) | unprognostic (1.60e-2) | unprognostic (2.68e-1) | unprognostic (3.98e-2) | unprognostic (2.26e-1) |
SNX11 | null | ENSG00000002919 | Sorting nexin 11 | Q9Y5W9 | 17 | 48103357-48123601 | Predicted intracellular proteins | Protein transport, Transport | null | null | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | Low tissue specificity | Detected in all | null | null | Cell type enhanced | Detected in all | null | Oocytes: 36.0 | Low cell type specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | Low immune cell specificity | Detected in all | null | null | Low lineage specificity | Detected in all | null | null | Low cancer specificity | Detected in all | null | null | null | Low region specificity | Detected in all | null | null | Low region specificity | Detected in all | null | null | HPA044787, HPA054660 | Approved | null | Approved | Endoplasmic reticulum,Vesicles | null | null | null | null | null | null | Cluster 28: Neutrophils - Unknown function | Cluster 70: Lymphoid tissue - Immune response | Cluster 13: Oligodendrocytes - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 14: Langerhans cells - Innate immune response | 10 | Endoplasmic reticulum | Vesicles | HPA044787: AB_10795988, HPA054660: AB_2682560 | unprognostic (8.83e-2) | unprognostic (7.86e-3) | unprognostic (2.35e-1) | unprognostic (9.77e-2) | unprognostic (4.46e-2) | unprognostic (1.01e-2) | unprognostic (9.13e-2) | unprognostic (6.92e-3) | unprognostic (9.92e-2) | unprognostic (7.29e-2) | unprognostic (3.06e-5) | unprognostic (4.02e-2) | unprognostic (5.99e-4) | unprognostic (2.27e-4) | unprognostic (2.62e-3) | unprognostic (3.47e-1) | unprognostic (1.67e-1) | unprognostic (4.76e-2) | unprognostic (2.08e-1) | unprognostic (5.54e-2) | unprognostic (6.57e-3) | unprognostic (1.31e-1) | unprognostic (3.67e-2) | unprognostic (2.52e-1) | unprognostic (1.46e-2) | unprognostic (1.73e-1) | unprognostic (2.08e-1) | unprognostic (2.21e-1) | unprognostic (1.63e-1) | unprognostic (1.37e-1) | unprognostic (1.13e-1) |
Human Protein Atlas v25: subcellular localization and full annotation tables
A verbatim mirror of three Human Protein Atlas (HPA) release files, packaged together with an explicit provenance and schema description. Nothing here is derived, filtered, or recomputed: the bytes are exactly what the upstream endpoints served.
The point of this repository is reproducibility. HPA serves only the current release at a stable URL, so a file downloaded six months from now will silently differ from the one used in a past experiment. Each file below is pinned with a SHA-256 and a retrieval date.
What HPA is
The Human Protein Atlas is a Swedish research program that maps the human proteome using antibody-based imaging, mass spectrometry, and transcriptomics. The subcellular section (the Cell Atlas) assigns proteins to organelles and subcellular structures by immunofluorescence (IF/ICC) in human cell lines, with a four-tier reliability grading. The measured entity is protein, but records are keyed by gene (ENSG), because HPA entries are gene-centric.
Files
| File | Size | Rows x Cols | HPA version | Retrieved | SHA-256 |
|---|---|---|---|---|---|
subcellular_location.tsv |
2,046,017 B | 13,603 x 14 | v25 | 2026-07-05 | 19ee031772375318e75556e43a5103cd8d919f7757094ef3fd134fba134fc095 |
proteinatlas.xml.gz |
729,899,935 B | 20,162 entries | v25 (declared in file) | 2026-04-21 | a8d12feab9d1c9846787fdd3f5efbe843d4247a898227830ff870ac18287f8ca |
unversioned_mirror/proteinatlas.tsv |
36,611,106 B | 20,162 x 107 | undetermined, pre-v25 | 2026-04-04 | 5f629a170520b747d12e2602471e0bbc2ee6a5c4968353f00143ffe26cec154a |
Upstream sources:
subcellular_location.tsvfromhttps://www.proteinatlas.org/download/tsv/subcellular_location.tsv.zip(unzipped, byte-identical to the archive member). UpstreamLast-Modifiedwas 2025-11-06, consistent with the v25.0 data drop (v25.0 released 2025-11-11).proteinatlas.xml.gzfromhttps://www.proteinatlas.org/download/proteinatlas.xml.gz. The file declares its own version:schemaLocation="https://v25.proteinatlas.org/download/proteinatlas.xsd",schemaVersion="3.0", and every<entry version="25">. Identifiers are Ensembl 109 on GRCh38.p13, GENCODE 43.gzip -tpasses.unversioned_mirror/proteinatlas.tsvwas not obtained from HPA directly. It came from a third-party data-lake mirror (the Biomni data lake). See the version warning below.
subcellular_location.tsv schema
13,603 genes, 14 tab-separated columns. This is the Cell Atlas summary table: one row per gene, aggregating IF observations across the cell lines that gene was stained in.
| # | Column | Non-null | Description |
|---|---|---|---|
| 1 | Gene |
100% | Ensembl gene ID (ENSG). 13,603 unique. The reliable join key. |
| 2 | Gene name |
100% | HGNC symbol. Only 13,597 unique, see caveats. |
| 3 | Reliability |
100% | Gene-level summary grade: Approved 6,999 / Supported 4,582 / Enhanced 1,230 / Uncertain 792 |
| 4 | Main location |
100% (13,602) | Primary localization, semicolon-separated, multi-label |
| 5 | Additional location |
46.5% | Secondary localization, semicolon-separated |
| 6 | Extracellular location |
5.4% | Single value Predicted to be secreted for 740 genes. A prediction, not a measurement. |
| 7 | Enhanced |
9.6% | Locations whose evidence reached the Enhanced tier |
| 8 | Supported |
38.7% | Locations at the Supported tier |
| 9 | Approved |
58.8% | Locations at the Approved tier |
| 10 | Uncertain |
17.9% | Locations at the Uncertain tier |
| 11 | Single-cell variation intensity |
26.8% | Compartments showing cell-to-cell intensity heterogeneity (3,650 genes) |
| 12 | Single-cell variation spatial |
1.4% | Compartments showing spatial heterogeneity (186 genes) |
| 13 | Cell cycle dependency |
3.5% | Cell-cycle-dependent structures (479 genes), e.g. Cytokinetic bridge, Mitotic spindle, Mitotic chromosome |
| 14 | GO id |
100% | Location terms with GO accessions, e.g. Cytosol (GO:0005829) |
How columns 7-10 relate to columns 4-5
These four columns are not a repeat of the reliability grade. They re-partition the same location labels by evidence strength. Verified on this file:
- For all 13,603 rows,
EnhancedUSupportedUApprovedUUncertainequalsMain locationUAdditional locationexactly. Zero exceptions. - 3,099 genes carry locations spanning more than one evidence tier (2 tiers: 2,806;
3 tiers: 292; 4 tiers: 1).
Reliabilityreports only that gene's best tier.
Practical consequence: to drop low-confidence localizations, remove the terms listed in the
Uncertain column, not the rows where Reliability == "Uncertain". The Uncertain column
is non-null for 2,430 genes but only 786 of those have Reliability == "Uncertain", so
row-level filtering leaves uncertain labels on 1,644 genes.
Multi-label structure
Main location count per gene: 1 location for 10,035 genes, 2 for 3,065, 3 for 407, 4 for 79,
5 for 10, 6 for 5, 7 for 1, and 1 gene with none. Additional location is empty for 7,277 genes.
Location vocabulary
49 distinct terms across Main location and Additional location, heavily skewed:
Nucleoplasm 6283, Cytosol 5267, Vesicles 2488, Plasma membrane 2263, Golgi apparatus 1279,
Mitochondria 1132, Nucleoli 1116, Nuclear bodies 626, Endoplasmic reticulum 576,
Centrosome 513, Nuclear speckles 507, Primary cilium 467, Basal body 451,
Principal piece 371, Microtubules 356, Mid piece 352, Cell Junctions 331,
Nucleoli fibrillar center 325, Nuclear membrane 295, Actin filaments 253,
Cytokinetic bridge 245, Centriolar satellite 228, End piece 195, Mitotic spindle 161,
Nucleoli rim 153, Focal adhesion sites 148, Intermediate filaments 147,
Primary cilium tip 130, Flagellar centriole 116, Acrosome 112,
Primary cilium transition zone 96, Connecting piece 92, Equatorial segment 82,
Mitotic chromosome 79, Cytoplasmic bodies 74, Perinuclear theca 70, Calyx 70,
Midbody 56, Annulus 50, Lipid droplets 40, Midbody ring 25, Peroxisomes 24,
Lysosomes 20, Rods & Rings 19, Aggresome 19, Endosomes 16, Kinetochore 8,
Microtubule ends 7, Cleavage furrow 2
Two terms (Nucleoplasm, Cytosol) account for a large share of all annotations. Any analysis that treats compartment sharing as a uniform feature will be dominated by these two.
proteinatlas.xml.gz
The complete HPA v25 release in XML, 20,162 gene entries, roughly 700 MB compressed. This is
the superset: everything in the TSV tables is derivable from it, plus data that has no TSV
equivalent. Per-entry sections include identifier, name, synonym, proteinClasses,
proteinEvidence, predictedLocation, antibody, tissueExpression, cellExpression,
cellTypeExpression, cancerExpression, rnaExpression, and proteinstructure.
The antibody blocks are the reason to use the XML rather than the TSV. They carry
per-antibody, per-cell-line IF results, including the individual imageUrl entries pointing
at the raw immunofluorescence JPGs on images.proteinatlas.org. The summary TSV collapses
all of that to one row per gene.
Stream it, do not load it. xml.etree.ElementTree.iterparse over gzip.open works fine
and keeps memory flat.
unversioned_mirror/proteinatlas.tsv and its version warning
20,162 genes x 107 columns: the wide per-gene annotation table covering protein class, tissue and single-cell RNA specificity, blood and brain expression, antibody reliability, subcellular location, secretome, expression clusters, and TCGA prognostics.
This file is not from a pinned HPA release and its version could not be determined. It was
mirrored from a third-party data lake, not from proteinatlas.org. It predates the v25 files
above: its cancer column is RNA cancer specific FPKM, whereas v25 uses RNA cancer specific pTPM.
Its subcellular columns also disagree with subcellular_location.tsv: Subcellular location
and Subcellular main location are non-null for 13,534 and 13,533 genes, against 13,603 and
13,602 in the v25 table.
It is included because it is a convenient wide-format annotation table, and because leaving it
out of a mirror while it circulates elsewhere unlabeled is worse than shipping it with the
caveat attached. Do not cite it as a specific HPA release. If you need the wide table at a
known version, download proteinatlas.tsv fresh from HPA and record the release number.
Caveats before you use this
- Cell-line context. HPA IF localization is measured mostly in U2OS, A-431, and U-251MG. The summary table is a cross-cell-line consensus, not a context-specific label. It does not describe localization in your cell line of interest.
- Antibody-dependent. Localization comes from antibody staining, so it inherits antibody specificity limits. The reliability tiers exist for this reason and should be used.
- Duplicate symbols.
Gene namehas 6 symbols appearing twice, each mapping to two distinct ENSGs: NPIPA9, POLR2J3, MATR3, HERC3, PRODH, PINX1. Keying by symbol silently drops or merges records. Key by ENSG. Extracellular locationis a prediction, not an observation, and should not be pooled with the measured location columns.- Gene-level keying. Records are per gene, so isoform-resolved or proteoform-resolved localization is not available here. Antibody epitopes usually span regions shared by isoforms, making each label an isoform mixture.
- Not a quantitative readout. These are categorical assignments with a reliability grade, not abundances or fractional distributions across compartments.
Not included
The raw immunofluorescence images (roughly 92,000 JPGs, about 28 GB) are not mirrored here.
Their URLs are inside proteinatlas.xml.gz under the antibody blocks and can be fetched
directly from images.proteinatlas.org.
License and citation
HPA data is released under CC BY 4.0, which permits redistribution with attribution. This mirror carries the same license. HPA notes that some integrated third-party datasets within the atlas may carry their own terms, so check before reusing a specific subset commercially.
Required attribution, per HPA: cite a primary publication and reference the Human Protein
Atlas with a versioned URL, https://v25.proteinatlas.org.
Cell Atlas primary reference:
Thul PJ, et al. A subcellular map of the human proteome. Science. 2017;356(6340):eaal3321.
Loading
import pandas as pd
loc = pd.read_csv("subcellular_location.tsv", sep="\t", dtype=str)
# correct low-confidence filtering: drop terms, not rows
def clean_locations(row):
keep = set()
for col in ("Main location", "Additional location"):
v = row[col]
if isinstance(v, str):
keep |= {x.strip() for x in v.split(";")}
unc = row["Uncertain"]
if isinstance(unc, str):
keep -= {x.strip() for x in unc.split(";")}
return keep
loc["locations"] = loc.apply(clean_locations, axis=1)
# stream the XML instead of loading it
import gzip, xml.etree.ElementTree as ET
with gzip.open("proteinatlas.xml.gz", "rb") as fh:
for _, elem in ET.iterparse(fh, events=("end",)):
if elem.tag == "entry":
...
elem.clear()
- Downloads last month
- 31